Pokaż uproszczony rekord

Estimating the Share of Sickness Absence Costs in Europe's GDP – a Country, Gender and Time Perspective

dc.contributor.authorMiszczyńska, Katarzyna M.
dc.contributor.authorAntczak, Elżbieta
dc.contributor.authorPrevolnik Rupel, Valentina
dc.date.accessioned2024-03-18T10:57:38Z
dc.date.available2024-03-18T10:57:38Z
dc.date.issued2023-12-30
dc.identifier.issn2391-6478
dc.identifier.urihttp://hdl.handle.net/11089/50832
dc.description.abstractThe purpose of the article. The aim of the study was to calculate and evaluate the costs of employee sickness absence in European countries over the period 2006–2020. An additional objective was to analyse the sensitivity of the development of absenteeism costs depending on the changing level of the discount rate used in economic evaluation analyses.Methodology. The estimation and subsequent assessment of absenteeism of working-age people costs was based on human-capital approach and was carried out retrospectively using the morbidity, top-down approach, based on aggregated epidemiological data. As a measure of production loss volume, GDP per working person was adopted.Results of the research. The study indicated that there is variation in the cost of sickness absence across European countries, but no clustering relationship was identified from a geographic perspective. In addition, SACS is in the range of 1,9% – 2,1% in all countries in 2006 prices.en
dc.language.isoen
dc.publisherWydawnictwo Uniwersytetu Łódzkiegopl
dc.relation.ispartofseriesFinanse i Prawo Finansowe;1pl
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.subjectcost-of-illness studiesen
dc.subjectindirect costs of illnessen
dc.subjectabsenteeismen
dc.subjecthuman capital approachen
dc.titleEstimating the Share of Sickness Absence Costs in Europe's GDP – a Country, Gender and Time Perspectiveen
dc.typeArticle
dc.page.number9-29
dc.contributor.authorAffiliationMiszczyńska, Katarzyna M. - University of Lodz, Faculty of Economics and Sociology, Department of Public Financeen
dc.contributor.authorAffiliationAntczak, Elżbieta - University of Lodz, Faculty of Economics and Sociology, Department of Spatial Econometricsen
dc.contributor.authorAffiliationPrevolnik Rupel, Valentina - Institute for Economic Research (IRF) Sloveniaen
dc.identifier.eissn2353-5601
dc.referencesAcemoglu, D., Johnson S. (2007). Disease and development: The effect of life expectancy on economic growth. Journal of Political Economy, 115(6), pp. 925–985. https://doi.org/10.1086/529000en
dc.referencesAnselin L., Florax R. J. (1995), New Directions in Spatial Econometrics, Springer Science & Business Media, http://dx.doi.org/10.1007/978-3-642-79877-1en
dc.referencesAntczak E., Miszczyńska, K. (2021), Causes of sickness absenteeism in Europe – analysis from an intercountry and gender perspective, International Journal of Environmental Research and Public Health, 18(22), https://doi.org/10.3390/ijerph182211823en
dc.referencesBloom D., Kotschy R., Prettner K., Canning D., Schünemann J. (2022), Health and Economic Growth: Reconciling the Micro and Macro Evidence, CESifo Working Paper, No. 9806, https://doi.org/10.2139/ssrn.4148203en
dc.referencesBrodszky V., Beretzky Z., Baji P., Rencz F., Péntek M., Rotar A., Tachkov K., Mayer S., Simon J., Niewada M., Hren R., Gulácsi L. (2019), Cost-of-illness studies in nine Central and Eastern European countries, European Journal of Health Economics, 20(s1), pp. 155–172, https://doi.org/10.1007/s10198-019-01066-xen
dc.referencesCleemput I., Neyt M., Van de Sande S., Thiry N. (2015), Belgian Guidelines for Economic Evaluations and Budget Impact Analyses, Second Edition.en
dc.referencesDrummond M., Sculpher M., Torrance G. (2005), Methods for the economic evaluation of health care programmes (3rd edition).en
dc.referencesErnst&Young (2013), Metodyka pomiaru kosztów pośrednich w polskim systemie ochrony zdrowia.en
dc.referencesEuropean Comm (2022), Euro area and EU working days to build Calendar Adjustment Regressor.en
dc.referencesHaacker M., Hallett T. B., Atun, R. (2020), On discount rates for economic evaluations in global health, Health Policy and Planning, 35(1), pp. 107–114, https://doi.org/10.1093/heapol/czz127en
dc.referencesJavaid K., Neidhardt M., Reynolds T., Cullen A., Anderson C. L., Long J., Manhart L., Anderson L., Investigator P. (2008), Morbidity and Economic Growth, Evans School Policy Analysis & Research Group (EPAR), Issue 293.en
dc.referencesJiang S., Wang Y., Si L., Zang X., Gu Y. Y., Jiang Y., Li, G. G., Wu, J. (2022), Incorporating productivity loss in health economic evaluations: A review of guidelines and practices worldwide for research agenda in China, BMJ Global Health, 7(8), pp. 1–14, https://doi.org/10.1136/bmjgh-2022-009777en
dc.referencesJo C. (2014), Cost-of-illness studies: concepts, scopes, and methods Clinical and Molecular Hepatology, pp. 327–337, http://dx.doi.org/10.3350/cmh.2014.20.4.327en
dc.referencesKoopmanschap M., Rutten F., van Ineveld B., van Roijen L. (1995), The friction cost method for measuring indirect costs of disease, Journal of Health Economics, 14(2), pp. 171–189, http://dx.doi.org/10.1016/0167-6296(94)00044-5en
dc.referencesKrol M., Brouwer W., Rutten, F. (2013), Productivity costs in economic evaluations: past, present, future. PharmacoEconomic, 31, pp. 537–54, https://doi.org/10.1007/s40273-013-0056-3en
dc.referencesKujawska J. (2015), Absencja chorobowa – szacunek niewytworzonego PKB, Studia Ekonomiczne, 214(214), pp. 264–275.en
dc.referencesKukuła K., Bogocz D. (2014), Zero Unitarization Method and its Application in Ranking Research in Agriculture, Economic and Regional Studies, 7(3), pp. 5–13.en
dc.referencesLotrič Dolinar A., Zvan, B., Došenović Bonča P. (2020), Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data, Zdravstveno Varstvo, 59(2), pp. 75–82, https://doi.org/10.2478/sjph-2020-0010en
dc.referencesLublóy Á. (2019), Economic burden of migraine in Latvia and Lithuania : direct and indirect costs, https://doi.org/10.1186/s12889-019-7461-2en
dc.referencesŁyszczarz B., Nojszewska E. (2017), Productivity losses and public finance burden attributable to breast cancer in Poland, BMC Cancer, http://doi.org/10.1186/s12885-017-3669-7en
dc.referencesMennini F. S., Gitto, L. (2022), Approaches To Estimating Indirect Costs in Healthcare: Motivations for Choice, Journal of European Economy, Vol, 21, No. 1, pp. 17–45. https://doi.org/10.35774/jee2022.01.017en
dc.referencesNachar N. (2008), The Mann-Whitney U: A Test for Assessing Whether Two Independent Samples Come from the Same Distribution, Tutorials in Quantitative Methods for Psychology, https://doi.org/10.20982/tqmp.04.1.p013en
dc.referencesNeubauer S., Welte R., Beiche A., Koenig H. H., Buesch K., Leidl R. (2006), Mortality, morbidity and costs attributable to smoking in Germany: Update and a 10-year comparison, Tobacco Control, 15(6), https://doi.org/10.1136/tc.2006.016030en
dc.referencesNicholas J. A., Electricwala B., Lee L. K., Johnson K. M. (2019), Burden of relapsing-remitting multiple sclerosis on workers in the US: A cross-sectional analysis of survey data, BMC Neurology, 19(1), pp. 1–13, https://doi.org/10.1186/s12883-019-1495-zen
dc.referencesNojszewska E. (2016), Ocena strat ekonomicznych i kosztów leczenia nowotworów piersi, szyjki macicy i jajnika w Polsce, Instytut Innowacyjna Gospodarka.en
dc.referencesOECD (2023), Employment by activity, https://doi.org/10.1787/a258bb52-enen
dc.referencesPederzoli V., Gandini, P. [eds] (2008), Analisi comparata sui costi dei laboratori di analisi di alcune strutture sanitarie: un’indagine per la determinazione dei costi delle prestazioni erogate https://www.icareviareggio.it/wp-content/uploads/ [Accessed: 14.02.2024]en
dc.referencesPuddu L., Rainero C., Scagliola L., Lusa C. (2016), La certificazione dei processi amministrativi nelle aziende sanitarie, Giappichelli Editore.en
dc.referencesRodríguez-Sánchez B., Daugbjerg S., Peña-Longobardo L. M., Oliva-Moreno J., Aranda-Reneo I., Cicchetti A., López-Bastida J. (2022), Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease, European Journal of Health Economics, Springer Berlin Heidelberg, https://doi.org/10.1007/s10198-022-01471-9en
dc.referencesSBU (2015), Methods for health economic evaluations – A guideline based on current practices in Europe, EUnetHTA, https://www.eunethta.eu/ [Accessed: 14.02.2024]en
dc.referencesSchultz T. (1961), Investment in Human Capital, The American Economic Review, 15(1), pp. 1–17.en
dc.referencesSoekhai V., de Bekker-Grob E. W., Ellis A. R., Vass C. M. (2019), Discrete Choice Experiments in Health Economics: Past, Present and Future, PharmacoEconomics, 37(2), pp. 201–226, https://doi.org/10.1007/s40273-018-0734-2en
dc.referencesTarricone R. (2006), Cost-of-illness analysis: what room in health economics?, Health Policy, pp. 51–63, https://doi.org/10.1016/j.healthpol.2005.07.016en
dc.referencesWilliams A. O., Rojanasarot S., McGovern A. M., Kumar A. (2023), A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications, Journal of Comparative Effectiveness Research, 12(2), https://doi.org/10.2217/cer-2022-0167en
dc.referencesWorld Bank (2022), How are aggregate growth rates computed for National Accounts series?, https://datahelpdesk.worldbank.org/knowledgebase/articles/ [Accessed: 14.02.2024].en
dc.referencesWorld Bank (2023), International Comparison Program https://data.worldbank.org/ [Accessed: 14.02.2024].en
dc.referencesWorld Health Organization (2022), European. Data Warehouse-European Health for All database (HFA-DB) https://gateway.euro.who.int/ [Accessed: 14.02.2024]en
dc.referencesZemedikun D. T., Kigozi J., Wynne-Jones G., Guariglia A., Roberts, T. (2021), Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review, PLoS ONE, pp. 1–17, https://doi.org/10.1371/journal.pone.0251406en
dc.contributor.authorEmailMiszczyńska, Katarzyna M. - katarzyna.miszczynska@uni.lodz.pl
dc.contributor.authorEmailAntczak, Elżbieta - elzbieta.antczak@uni.lodz.pl
dc.contributor.authorEmailPrevolnik Rupel, Valentina - rupelv@ier.si
dc.identifier.doi10.18778/2391-6478.S1.2023.01


Pliki tej pozycji

Thumbnail
Nazwa:
9-29-Miszczynska_Antczak_Rupel.pdf
Rozmiar:
1.297MB
Format:
PDF
Oglądaj/Otwórz

Pozycja umieszczona jest w następujących kolekcjach

Pokaż uproszczony rekord

https://creativecommons.org/licenses/by-nc-nd/4.0
Poza zaznaczonymi wyjątkami, licencja tej pozycji opisana jest jako https://creativecommons.org/licenses/by-nc-nd/4.0